Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular ...
The new full visual range IOL*1 delivers exceptional distance vision2 and 14% smaller readable print size vs PanOptix3 †. 93% of patients become free from glasses at all distances.#4 ‑ TECNIS Odyssey ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
ClearSight is now offering the Tecnis Odyssey Lens, a next-generation intraocular lens (IOL) designed for patients undergoing cataract surgery or Custom Lens Replacement. This advanced lens technology ...
AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ β€” Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...
Please provide your email address to receive an email when new articles are posted on . The Tecnis Synergy and Tecnis Synergy Toric II IOLs are now available for patients undergoing cataract surgery ...
SANTA ANA, Calif., Feb. 2, 2021 /PRNewswire/ -- Johnson & Johnson Vision**, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies***, today announced that the U.S.
Johnson & Johnson is expanding the US roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) lens designed to ...
TECNIS Odyssey IOL offers higher tolerance to residual refractive errors, enabling surgeons to deliver consistent and reliable patient outcomes. 5¶ Experience the ...